relatively healthy male
Showing 1 - 25 of >10,000
Relatively Healthy Male Veterans Observed Over Time to See What
Completed
- Healthy
-
Loma Linda, California
- +8 more
Jan 29, 2021
Healthy Male Subjects Trial in Shanghai ([14C] Yiqibuvir)
Not yet recruiting
- Healthy Male Subjects
- [14C] Yiqibuvir
-
Shanghai, Shanghai, ChinaShanghai xuhui central hospital
Aug 16, 2023
Healthy Male Subjects Trial (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection, Pembrolizumab
Not yet recruiting
- Healthy Male Subjects
- Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection
- Pembrolizumab injection
- (no location specified)
Oct 30, 2023
Healthy Male Subjects Trial in Brooklyn (Savolitinib, Fluvoxamine)
Not yet recruiting
- Healthy Male Subjects
-
Brooklyn, MarylandResearch Site
May 25, 2023
Healthy Volunteers Trial (Liposomal Amikacin for Inhalation)
Completed
- Healthy Volunteers
- Liposomal Amikacin for Inhalation
- (no location specified)
Aug 11, 2023
Healthy Male Subjects Trial in Lincoln (14C RPT193)
Not yet recruiting
- Healthy Male Subjects
- 14C RPT193
-
Lincoln, NebraskaCelerion
Oct 13, 2023
Healthy Male Trial in Beijing (Envafolimab with new manufacturing process, Envafolimab with old manufacturing process)
Not yet recruiting
- Healthy Male
- Envafolimab with new manufacturing process
- Envafolimab with old manufacturing process
-
Beijing, Beijing, ChinaBeijing Gaobo Boren Hosipital
May 9, 2023
Healthy Male Subjects Trial in Shanghai ([14C] Antaitavir Hasophate)
Completed
- Healthy Male Subjects
- [14C] Antaitavir Hasophate
-
Shanghai, Shanghai, ChinaShanghai xuhui central hospital
Jan 4, 2023
Healthy Male Subjects Trial (tafolecimab (a modified manufacturing process), tafolecimab (a original manufacturing process))
Not yet recruiting
- Healthy Male Subjects
- tafolecimab (a modified manufacturing process)
- tafolecimab (a original manufacturing process)
- (no location specified)
Mar 29, 2023
Phase 1 Study, Healthy Volunteers Trial in Beijing ([14C]DWP14012)
Active, not recruiting
- Phase 1 Study, Healthy Volunteers
-
Beijing, ChinaBeijing GoBroad Boren Hospital
May 11, 2023
Healthy Male Subjects Trial in Changsha (sintilimab (after the change), sintilimab (before the change))
Recruiting
- Healthy Male Subjects
- sintilimab (after the change)
- sintilimab (before the change)
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Dec 5, 2022
Healthy Trial in Madison (Fadraciclib)
Active, not recruiting
- Healthy
-
Madison, WisconsinLabcorp Clinical Research Unit
Apr 5, 2023
Immune System Disorder (Healthy Volunteer) Trial in Baltimore (Belumosudil mesylate, Placebo)
Completed
- Immune System Disorder (Healthy Volunteer)
- Belumosudil mesylate
- Placebo
-
Baltimore, MarylandInvestigational site
Jun 15, 2023
Healthy Trial (Daridorexant 10 mg, Daridorexant 25 mg)
Not yet recruiting
- Healthy
- Daridorexant 10 mg
- Daridorexant 25 mg
- (no location specified)
Jun 1, 2023
Non-invasive Urine Output Management Trial in Tampa (PureWick Male External Catheter, Sage PrimoFit)
Completed
- Non-invasive Urine Output Management
- PureWick Male External Catheter
- Sage PrimoFit
-
Tampa, FloridaUSF Health Center for Advanced Medical Learning and Simulation (
Jul 13, 2023
Healthy Trial in Madison ([14C]-LY3871801)
Not yet recruiting
- Healthy
-
Madison, WisconsinCovance Clinical Research Unit
Sep 15, 2023
This is a Phase Study Conducted in Healthy Volunteers, Osteoporosis Trial (Denosumab)
Not yet recruiting
- This is a Phase Study Conducted in Healthy Volunteers
- Osteoporosis
- Denosumab
- (no location specified)
May 17, 2023
